<DOC>
	<DOCNO>NCT00091312</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , irinotecan , leucovorin , fluorouracil , work different way stop tumor cell divide stop grow die . Combining one drug give surgery may kill remain tumor cell . It yet know whether combination chemotherapy effective observation alone treat patient undergone surgery colon cancer . PURPOSE : This randomized phase III trial study irinotecan fluorouracil without leucovorin see well work compare observation alone treat patient undergone surgery stage II colon cancer .</brief_summary>
	<brief_title>Fluorouracil Irinotecan With Without Leucovorin Compared With Observation Treating Patients Who Have Undergone Surgery Stage II Colon Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Compare 5-year disease-free survival patient resect stage II adenocarcinoma colon treat adjuvant chemotherapy comprise fluorouracil irinotecan without leucovorin calcium v adjuvant therapy . Secondary - Compare 8-year overall survival patient treat regimen . - Compare tolerability regimens patient . - Correlate clinical , histological , biological prognostic factor outcome patient treat regimen . OUTLINE : This randomize , multicenter study . Patients stratify accord participate center , disease stage ( pT3 v pT4 ) , pathological differentiation ( poorly undifferentiated vs well moderately differentiate ) , microsatellite instability ( positive v negative v unknown ) . Patients randomize 1 2 treatment arm . - Arm I : Patients randomize receive 1 3 adjuvant chemotherapy regimen . - Regimen A : Patients receive irinotecan IV 90 minute follow leucovorin calcium IV 2 hour fluorouracil IV continuously 46 hour day 1 , 15 , 29 . Treatment repeat every 42 day 4 course absence disease progression unacceptable toxicity . - Regimen B : Patients receive irinotecan IV 30-90 minute follow leucovorin calcium IV 2 hour fluorouracil IV continuously 24 hour day 1 , 8 , 15 , 22 , 29 , 36 . Treatment repeat every 56 day 4 course absence disease progression unacceptable toxicity . - Regimen C : Patients receive irinotecan IV 60 minute follow fluorouracil IV continuously 48 hour day 1 , 8 , 15 , 22 , 29 , 36 . Treatment repeat every 42 day 4 course absence disease progression unacceptable toxicity . - Arm II : Patients undergo observation . Patients follow every 6 month . PROJECTED ACCRUAL : A total 1,976 patient ( 988 per treatment arm [ 247 regimens A B arm I 494 regimen C arm I ] ) accrue study within 4.5 year .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm adenocarcinoma colon Stage II disease ( pT3 , N0 pT4 , N0 ) Penetration subserosa serosa No lymph node metastasis At least 12 lymph node analyze More 1 synchronous primary colon tumor allow Staging determine advanced tumor Curative radical resection within past 28 week require Proximal , distal , radical margin must free tumor ( R0 resection ) No rectal tumor Gross distal margin primary tumor must lie peritoneal reflection No know familial adenomatous polyposis No hereditary nonpolyposis colorectal cancer No distant metastasis PATIENT CHARACTERISTICS : Age 18 75 Performance status WHO 01 Life expectancy Not specify Hematopoietic Granulocyte count ≥ 2,000/mm^3 Platelet count ≥ 100,000mm^3 Hemoglobin ≥ 10 g/dL Hepatic Bilirubin &lt; 1.25 time upper limit normal ( ULN ) No known Gilbert 's syndrome Renal Creatinine &lt; 1.25 time ULN Cardiovascular No severe uncontrolled coronary disease No severe heart failure No uncontrolled arterial hypertension No myocardial infarction within past year No cerebral vascular accident within past year Cardiac arrhythmia allow provided patient proper anticoagulation therapy* NOTE : *Aspirin consider proper anticoagulation Gastrointestinal No Gardner 's syndrome No Turcot 's syndrome No Crohn 's disease No ulcerative colitis Other No prior malignancy except adequately treat basal cell skin cancer carcinoma situ cervix No serious disease No contraindication study drug No know allergy leucovorin calcium Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception 6 month study treatment PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy No prior chemotherapy Endocrine therapy Not specify Radiotherapy No prior radiotherapy Surgery See Disease Characteristics Other No concurrent anticancer therapy No concurrent vitamin supplement contain folic acid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>stage II colon cancer</keyword>
	<keyword>adenocarcinoma colon</keyword>
</DOC>